Latest On Ironwood Pharmaceuticals, Inc (IRWD):
| Date/Time | Type | Description | Signal | Details |
|---|---|---|---|---|
| 2023-05-22 08:54 EST | News | Ironwood falls 15% on deal to buy VectivBio for $17/share cash | N/A |  |
| 2023-05-07 06:21 EST | News | Ironwood Pharmaceuticals, Inc. (IRWD) Q1 2023 Earnings Call Transcript | N/A | |
| 2023-05-04 13:18 EST | News | Ironwood Pharmaceuticals Non-GAAP EPS of $0.25 beats by $0.01, revenue of $104.06M beats by $3.46M | N/A | |
| 2023-05-04 00:56 EST | News | Ironwood Pharmaceuticals Q1 2023 Earnings Preview | N/A | |
| 2023-04-13 22:50 EST | News | Ironwood Pharmaceuticals gains amid activist speculation | N/A | |
| 2023-04-11 15:09 EST | News | Ironwood Pharmaceuticals to eliminate COO role | N/A | |
| 2023-02-16 14:50 EST | News | Ironwood Pharmaceuticals Non-GAAP EPS of $0.27 beats by $0.01, revenue of $107.2M misses by $1.02M, guidance in-line | N/A | |
| 2023-02-16 14:50 EST | News | Ironwood Pharmaceuticals, Inc. 2022 Q4 - Results - Earnings Call Presentation | N/A | |
| 2023-02-16 14:49 EST | News | Ironwood Pharmaceuticals, Inc. (IRWD) Q4 2022 Earnings Call Transcript | N/A | |
| 2023-02-13 07:56 EST | News | AbbVie, Ironwood Linzess gets FDA priority review to treat functional constipation in children | N/A | |
| 2023-01-12 23:21 EST | News | Ironwood Pharmaceuticals (IRWD) Presents at the 41st Annual J.P. Morgan Healthcare Conference -- Slideshow | N/A | |
| 2022-11-04 04:11 EST | News | Ironwood Pharmaceuticals, Inc. (IRWD) Q3 2022 Earnings Call Transcript | N/A | |
| 2022-11-03 10:50 EST | News | Ironwood Pharmaceuticals Non-GAAP EPS of $0.28 beats by $0.01, revenue of $108.64M misses by $1.76M, reaffirms FY guidance | N/A | |
| 2022-10-05 22:54 EST | News | Ironwood Pharmaceuticals: Rinse, Wash And Repeat | N/A | |
| 2022-09-06 10:21 EST | News | AbbVie, Ironwood constipation therapy Linzess meets main goal of phase 3 trial in children | N/A | |
| 2022-08-06 10:54 EST | News | Ironwood Pharmaceuticals, Inc. (IRWD) CEO Tom McCourt on Q2 2022 Results - Earnings Call Transcript | N/A | |
| 2022-08-05 19:46 EST | News | Ironwood Pharmaceuticals, Inc. 2022 Q2 - Results - Earnings Call Presentation | N/A | |
| 2022-08-04 12:40 EST | News | Ironwood Pharmaceuticals reports Q2 earnings miss; reaffirms FY22 guidance | N/A | |
| 2022-08-03 22:08 EST | News | Ironwood Pharmaceuticals Q2 2022 Earnings Preview | N/A | |
| 2022-07-30 04:58 EST | News | Ironwood Pharma falls 7% as Linzess Q2 sales of drug from AbbVie weigh | N/A | |
| 2022-05-08 17:53 EST | News | Ironwood Pharmaceuticals, Inc. (IRWD) CEO Tom McCourt on Q1 2022 Results - Earnings Call Transcript | N/A | |
| 2022-05-06 04:09 EST | News | Ironwood Pharmaceuticals Non-GAAP EPS of $0.21, revenue of $98M | N/A | |
| 2022-05-05 04:57 EST | News | Ironwood Pharmaceuticals Q1 2022 Earnings Preview | N/A | |
| 2022-04-22 13:29 EST | News | Ironwood Pharmaceuticals initiated at overweight at Piper on cash flow from Linzess | N/A | |
| 2022-02-18 16:15 EST | News | Ironwood Pharmaceuticals, Inc.'s (IRWD) CEO Thomas McCourt on Q4 2021 Results - Earnings Call Transcript | N/A | |
| 2022-02-17 19:01 EST | News | Ironwood Pharmaceuticals Non-GAAP EPS of $0.27 misses by $0.07, revenue of $117.13M beats by $6.96M | N/A | |
| 2022-02-17 19:01 EST | News | Ironwood Pharmaceuticals, Inc. 2021 Q4 - Results - Earnings Call Presentation | N/A | |
| 2022-02-17 19:01 EST | News | Ironwood Pharmaceuticals, Inc. (IRWD) CEO Thomas McCourt on Q4 2021 Results - Earnings Call Transcript | N/A | |
| 2022-02-16 22:26 EST | News | Ironwood Pharmaceuticals Q4 2021 Earnings Preview | N/A | |
| 2022-01-15 01:26 EST | News | Ironwood Pharmaceuticals (IRWD) presents at JP Morgan 40th Annual Virtual Healthcare Conference (Slideshow) | N/A | |
| 2022-01-10 21:10 EST | News | Ironwood Pharmaceuticals sees FY21 guidance ahead of prior levels, provides FY22 estimates | N/A | |
| 2021-12-01 23:58 EST | News | Ironwood names Sravan Emany as CFO | N/A | |
| 2021-12-01 23:57 EST | News | Ironwood Pharmaceuticals gains on takeout speculation with CFO hiring | N/A | |
| 2021-11-06 22:18 EST | News | Ironwood Pharmaceuticals, Inc. (IRWD) CEO Tom McCourt on Q3 2021 Results - Earnings Call Transcript | N/A | |
| 2021-11-05 08:07 EST | News | Ironwood Pharmaceuticals, Inc. 2021 Q3 - Results - Earnings Call Presentation | N/A | |
| 2021-11-04 11:05 EST | News | Ironwood Pharmaceuticals EPS beats by $0.01, misses on revenue | N/A | |
| 2021-11-04 11:05 EST | News | Ironwood inks collaboration and license option agreement with COUR Pharmaceutical | N/A | |
| 2021-11-03 13:59 EST | News | Ironwood Pharmaceuticals Q3 2021 Earnings Preview | N/A | |
| 2021-09-27 19:35 EST | News | Ironwood Pharmaceuticals: Undervalued Company With Steady Growth | N/A | |
| 2021-08-26 14:54 EST | News | Ironwood Pharma pops 7% on FDA approval of revised Lizness label | N/A | |
| 2021-08-10 06:03 EST | News | Ironwood Pharmaceuticals, Inc. 2021 Q2 - Results - Earnings Call Presentation | N/A | |
| 2021-08-08 14:03 EST | News | Ironwood Pharmaceuticals, Inc. (IRWD) CEO Tom McCourt on Q2 2021 Results - Earnings Call Transcript | N/A | |
| 2021-08-06 05:08 EST | News | Ironwood Pharmaceuticals EPS beats by $0.12, beats on revenue | N/A | |
| 2021-08-05 06:49 EST | News | Ironwood Pharmaceuticals Q2 2021 Earnings Preview | N/A | |
| 2021-07-21 12:48 EST | News | Ironwood Pharma announces agreement with Teva for generic version of LINZESS | N/A | |
| 2021-07-21 12:45 EST | News | Ironwood Pharmaceuticals names Thomas McCourt permanent CEO | N/A | |
| 2021-07-21 12:33 EST | News | Ironwood Pharmaceuticals gains on takeover speculation after 8-K filing (update) | N/A | |
| 2021-05-06 14:04 EST | News | Ironwood Pharmaceuticals EPS beats by $0.03, misses on revenue; reaffirms guidance | N/A | |
| 2021-05-06 14:04 EST | News | Ironwood Pharmaceuticals announces $150M share buyback | N/A | |
| 2021-05-05 18:07 EST | News | Ironwood Pharmaceuticals Q1 2021 Earnings Preview | N/A | |
About Ironwood Pharmaceuticals, Inc (IRWD):
Ironwood Pharmaceuticals, Inc., a healthcare company, focuses on the development and commercialization of gastrointestinal (GI) products. It markets linaclotide, a guanylate cyclase type-C agonist for the treatment of adults suffering from irritable bowel syndrome with constipation (IBS-C) or chronic idiopathic constipation (CIC) under the LINZESS name in the United States and Mexico, as well as under the CONSTELLA name in the Canada and European Union. The company is also developing IW-3300, a GC-C agonist, which is in pre-clinical development for the treatment of visceral pain conditions, including interstitial cystitis/bladder pain syndrome and endometriosis. It has strategic partnerships with AbbVie Inc., AstraZeneca AB, and Astellas Pharma Inc. for the development and commercialization of linaclotide. The company was formerly known as Microbia, Inc. and changed its name to Ironwood Pharmaceuticals, Inc. in April 2008. Ironwood Pharmaceuticals, Inc. was incorporated in 1998 and is headquartered in Boston, Massachusetts.
General
- Name Ironwood Pharmaceuticals, Inc
- Symbol IRWD
- Type Common Stock
- Exchange NASDAQ
- Currency USD
- Country USA
- SectorHealthcare
- IndustryDrug Manufacturers-Specialty & Generic
- Full Time Employees 232
- Last Split Factor1194:1000
- Last Split Date2019-04-02
- Fiscal Year EndDecember
- IPO Date2010-02-03
- Gic SectorHealth Care
- Gic GroupPharmaceuticals, Biotechnology & Life Sciences
- Gic IndustryBiotechnology
- Gic SubIndustryBiotechnology
- Web URLhttp://www.ironwoodpharma.com
View More
Valuation
- Trailing PE 17
- Forward PE 10.86
- Price/Sales (Trailing 12 Mt.) 4.76
- Price/Book (Most Recent Quarter) 29.63
- Enterprise Value Revenue 5
- Enterprise Value EBITDA 13.72
View More
Financials
- Most Recent Quarter 2020-12-31
- Current Year EPS Estimate $0.96
- Next Year EPS Estimate $1.05
- Next Quarter EPS Estimate $0.19
- Profit Margin 27%
- Operating Margin 41%
- Return on Assets 21%
- Revenue 389.52 million
- Earnings Per Share $0.66
- Revenue Per Share $2.44
- Gross Profit 298.33 million
- Quarterly Earnings Growth -7.6%
View More
Highlights
- Market Capitalization 1.81 billion
- EBITDA 161.29 million
- PE Ratio 87.74
- PEG Ratio -0.26
- Analyst Target Price $11
- Book Value Per Share $0.39
View More
Share Statistics
- Shares Outstanding 160.96 million
- Shares Float 140.01 million
- % Held by Insiders 296%
- % Held by Institutions 108.52%
- Shares Short 17.91 million
- Shares Short Prior Month 18.17 million
- Short Ratio 9.23
- Short % of Float 17%
- Short % of Shares Outstanding 11%
View More
Technicals
- Beta 1.35
- 52 Week High $12.55
- 52 Week Low $8.63
- 50 Day Moving Average 10.2
- 200 Day Moving Average 10.57
View More
Dividends
- Dividend Date N/A
- ExDividend Date N/A
- Dividend Yield 0%
View More
Ironwood Pharmaceuticals, Inc (IRWD) Dividend Calendar:
| Ex-Dividend Date | Payment Date | Record Date | Declared Date | Amount |
|---|
Ironwood Pharmaceuticals, Inc (IRWD) Earnings History:
Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.
| Quarter Date | Report Date | Actual Revenue | Reported EPS | EPS Estimate | Deviation from Estimate |
|---|---|---|---|---|---|
| 2020-12-31 | 2021-02-17 | $116.68 million | $0.36 | $0.29 | 25% |
| 2020-09-30 | 2020-11-05 | $103.47 million | $0.23 | $0.15 | 51.32% |
| 2020-06-30 | 2020-08-06 | $N/A | $0.16 | $0.10 | 56.1% |
| 2020-03-31 | 2020-05-06 | $79.94 million | $0.04 | $0.05 | -13.04% |
| 2019-12-31 | 2020-02-13 | $126.3 million | $0.30 | $0.24 | 25% |
| 2019-09-30 | 2019-10-31 | $131.17 million | $0.40 | $0.12 | 241.01% |
| 2019-06-30 | 2019-07-30 | $102.22 million | $0.10 | -$0.03 | 500% |
| 2019-03-31 | 2019-05-02 | $68.73 million | -$0.26 | -$0.23 | -14.69% |
| 2018-12-31 | 2019-02-13 | $130.69 million | -$0.02 | -$0.19 | 89.38% |
| 2018-09-30 | 2018-11-06 | $65.69 million | -$0.38 | -$0.20 | -91.63% |
| 2018-06-30 | 2018-08-06 | $81.11 million | -$0.28 | -$0.23 | -24.06% |
| 2018-03-31 | 2018-05-01 | $69.16 million | -$0.27 | -$0.21 | -25.99% |
| 2017-12-31 | 2018-02-15 | $94.21 million | -$0.14 | -$0.20 | 31.57% |
| 2017-09-30 | 2017-11-02 | $86.83 million | -$0.18 | -$0.24 | 25.37% |
| 2017-06-30 | 2017-08-03 | $65.08 million | -$0.28 | -$0.23 | -22.32% |
| 2017-03-31 | 2017-05-08 | $52.17 million | -$0.33 | -$0.21 | -53.99% |
| 2016-12-31 | 2017-02-21 | $87.46 million | -$0.12 | -$0.22 | 46.07% |
| 2016-09-30 | 2016-11-03 | $66.11 million | -$0.18 | -$0.23 | 22.21% |
| 2016-06-30 | 2016-08-04 | $54.35 million | -$0.16 | -$0.16 | 0.81% |
| 2016-03-31 | 2016-05-09 | $66.04 million | -$0.08 | -$0.17 | 51.54% |
| 2015-12-31 | 2016-02-18 | $53.31 million | -$0.10 | -$0.18 | 43.05% |
| 2015-09-30 | 2015-11-03 | $39.57 million | -$0.33 | -$0.20 | -65% |
| 2015-06-30 | 2015-08-05 | $27.74 million | -$0.34 | -$0.22 | -54.55% |
| 2015-03-31 | 2015-05-05 | $28.93 million | -$0.24 | -$0.23 | -4.35% |
| 2014-12-31 | 2015-02-12 | $38.07 million | -$0.27 | -$0.21 | -28.57% |
| 2014-09-30 | 2014-11-04 | $16.92 million | -$0.30 | -$0.32 | 6.25% |
| 2014-06-30 | 2014-08-04 | $6.84 million | -$0.44 | -$0.36 | -22.22% |
| 2014-03-31 | 2014-04-29 | $14.61 million | -$0.38 | -$0.43 | 11.63% |
| 2013-12-31 | 2014-01-21 | $5.03 million | -$0.43 | -$0.50 | 14% |
| 2013-09-30 | 2013-10-22 | $4.93 million | -$0.51 | -$0.57 | 10.53% |
| 2013-06-30 | 2013-07-23 | $9.66 million | -$0.57 | -$0.68 | 16.18% |
| 2013-03-31 | 2013-04-23 | $3.26 million | -$0.82 | -$0.64 | -28.13% |
| 2012-12-31 | 2013-01-15 | $26.98 million | -$0.41 | -$0.47 | 12.77% |
| 2012-09-30 | 2012-10-16 | $96.41 million | $0.42 | $0.13 | 223.08% |
| 2012-06-30 | 2012-07-17 | $14.6 million | -$0.38 | -$0.32 | -18.75% |
| 2012-03-31 | 2012-05-01 | $12.25 million | -$0.34 | -$0.24 | -41.67% |
| 2011-12-31 | 2012-02-28 | $32.15 million | -$0.07 | -$0.11 | 36.36% |
| 2011-09-30 | 2011-11-07 | $12.22 million | -$0.21 | -$0.21 | 0% |
| 2011-06-30 | 2011-08-11 | $11.26 million | -$0.19 | -$0.19 | 0% |
| 2011-03-31 | 2011-05-12 | $10.24 million | -$0.19 | -$0.17 | -11.76% |
| 2010-12-31 | 2011-03-03 | $16.77 million | -$0.12 | -$0.14 | 14.29% |
| 2010-09-30 | 2010-11-04 | $9.06 million | -$0.08 | -$0.19 | 57.89% |
| 2010-06-30 | 2010-08-05 | $9.19 million | -$0.18 | -$0.19 | 5.26% |
| 2010-03-31 | 2010-05-11 | $8.84 million | -$0.25 | -$0.16 | -56.25% |
| 2009-12-31 | 2010-03-30 | $8.4 million | -$3.30 | -$0.20 | -1550% |
Ironwood Pharmaceuticals, Inc (IRWD) Company Financial Statements:
Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.
Income Statement:
| Date |
|---|
| Research Development |
| Income Before Tax |
| Selling General Administrative |
| Gross Profit |
| Ebit |
| Operating Income |
| Income Tax Expense |
| Total Revenue |
| Cost of Revenue |
| Total Other Income Expense Net |
| Net Income From Continuing Operations |
| Net Income Applicable to Common Shares |
Cash Flow:
| Date |
|---|
| Investments |
| Change to Liabilities |
| Total Cash Flow from Investing Activities |
| Net Borrowings |
| Total Cash Flow from Financial Activities |
| Change to Operating Activities |
| Change in Cash |
| Total Cash from Operating Activities |
| Depreciation |
| Other Cash Flow from Investing Activities |
| Change to Inventory |
| Change to Account Receivables |
| Other Cash Flow from Financing Activities |
| Change to Net Income |
| Capital Expenditures |
Balance Sheet:
| Date |
|---|
| Total Liabailities |
| Total Stockholder Equity |
| Other Current Liabilities |
| Total Assets |
| Common Stock |
| Other Current Assets |
| Retained Earnings |
| Other Liabilities |
| Other Assets |
| Cash |
| Total Current Liabilities |
| Other Stockholder Equity |
| Property, Plant & Equipment |
| Total Current Assets |
| Long Term Investments |
| Net Tangible Assets |
| Short Term Investments |
| Long Term Debt |
| Inventory |
| Accounts Payable |
Ironwood Pharmaceuticals, Inc (IRWD) Chart:
Ironwood Pharmaceuticals, Inc (IRWD) News:
Below you will find a list of latest news for Ironwood Pharmaceuticals, Inc (IRWD) from major news sources. You can filter the results to only show news from a specific source.
No recent news available
Ironwood Pharmaceuticals, Inc (IRWD) Options:
A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.
| Expiration Date | Strike | Last Price | Type | Volume | Open Interest | Implied Volatility | In The Money | Change | Change Percent |
|---|---|---|---|---|---|---|---|---|---|
| 2025-03-21 | 2.5 | 0.07 | CALL | 0 | 288 | 165.99 | FALSE | 0 | 0 |
| 2025-03-21 | 5 | 0.1 | CALL | 0 | 4 | 244.7 | FALSE | 0 | 0 |
| 2025-03-21 | 7.5 | 0.05 | CALL | 0 | 2 | 487.82 | FALSE | 0 | 0 |
| 2025-03-21 | 2.5 | 0.8 | PUT | 0 | 2 | 217.74 | TRUE | 0 | 0 |
| 2025-03-21 | 5 | 2.7 | PUT | 0 | 22 | 272.1 | TRUE | 0 | 0 |
| 2025-03-21 | 7.5 | 0 | PUT | 0 | 0 | 0 | TRUE | 0 | 0 |
| 2025-04-17 | 2.5 | 0 | CALL | 0 | 0 | 677.24 | FALSE | 0 | 0 |
| 2025-04-17 | 5 | 0 | CALL | 0 | 0 | 731.67 | FALSE | 0 | 0 |
| 2025-04-17 | 7.5 | 0 | CALL | 0 | 0 | 777.49 | FALSE | 0 | 0 |
| 2025-04-17 | 2.5 | 0 | PUT | 0 | 0 | 114.86 | TRUE | 0 | 0 |
| 2025-04-17 | 5 | 0 | PUT | 0 | 0 | 0 | TRUE | 0 | 0 |
| 2025-04-17 | 7.5 | 0 | PUT | 0 | 0 | 252.28 | TRUE | 0 | 0 |
| 2025-05-16 | 2.5 | 0.16 | CALL | 0 | 219 | 88.61 | FALSE | 0 | 0 |
| 2025-05-16 | 5 | 0.06 | CALL | 0 | 253 | 129.27 | FALSE | 0 | 0 |
| 2025-05-16 | 7.5 | 0.06 | CALL | 0 | 163 | 202.41 | FALSE | 0 | 0 |
| 2025-05-16 | 2.5 | 0.75 | PUT | 0 | 4 | 150.57 | TRUE | 0 | 0 |
| 2025-05-16 | 5 | 0 | PUT | 0 | 0 | 166.25 | TRUE | 0 | 0 |
| 2025-05-16 | 7.5 | 5.3 | PUT | 0 | 0 | 0 | TRUE | 0 | 0 |
| 2025-08-15 | 2.5 | 0.4 | CALL | 3 | 504 | 80.25 | FALSE | 0.4 | 0 |
| 2025-08-15 | 5 | 0.1 | CALL | 0 | 124 | 689.57 | FALSE | 0 | 0 |
| 2025-08-15 | 7.5 | 0.25 | CALL | 0 | 28 | 139.98 | FALSE | 0 | 0 |
| 2025-08-15 | 2.5 | 0.85 | PUT | 0 | 13 | 78.74 | TRUE | 0 | 0 |
| 2025-08-15 | 5 | 0 | PUT | 0 | 0 | 122.27 | TRUE | 0 | 0 |
| 2025-08-15 | 7.5 | 5.2 | PUT | 0 | 8 | 139.73 | TRUE | 0 | 0 |
Latest IRWD Trades:
| Date | Shares | Price |
|---|---|---|
| Jun 13, 2022 7:59 PM EST | 300 | $11.685 |
| Jun 13, 2022 7:59 PM EST | 100 | $11.68 |
| Jun 13, 2022 7:59 PM EST | 1 | $11.68 |
| Jun 13, 2022 7:59 PM EST | 1 | $11.67 |
| Jun 13, 2022 7:59 PM EST | 999 | $11.67 |
Ironwood Pharmaceuticals, Inc (IRWD) SEC Filings:
An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.
| Date | Form Type | Form Name | Link |
|---|---|---|---|
| 2020-06-16 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1446847/000120919120037035/0001209191-20-037035-index.htm |
| 2020-02-07 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1446847/000031506620001036/0000315066-20-001036-index.htm |
| 2020-02-05 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1446847/000083423720005909/0000834237-20-005909-index.htm |
| 2020-02-12 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1446847/000086117720000002/0000861177-20-000002-index.htm |
| 2019-05-16 | SC 13D | General statement of acquisition of beneficial ownership | https://www.sec.gov/Archives/edgar/data/1446847/000089914019000402/0000899140-19-000402-index.htm |
| 2020-02-26 | SC 13D/A | General statement of acquisition of beneficial ownership | https://www.sec.gov/Archives/edgar/data/1446847/000089914020000196/0000899140-20-000196-index.htm |
| 2020-01-28 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1446847/000090221920000252/0000902219-20-000252-index.htm |
| 2019-04-12 | PRE 14A | Other preliminary proxy statements | https://www.sec.gov/Archives/edgar/data/1446847/000104746919002215/0001047469-19-002215-index.htm |
| 2019-04-26 | DEF 14A | Other definitive proxy statements | https://www.sec.gov/Archives/edgar/data/1446847/000104746919002641/0001047469-19-002641-index.htm |
| 2020-04-21 | DEF 14A | Other definitive proxy statements | https://www.sec.gov/Archives/edgar/data/1446847/000104746920002477/0001047469-20-002477-index.htm |
| 2019-03-08 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1446847/000110465919013536/0001104659-19-013536-index.htm |
| 2019-03-14 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1446847/000110465919014911/0001104659-19-014911-index.htm |
| 2019-03-14 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1446847/000110465919014912/0001104659-19-014912-index.htm |
| 2019-03-28 | 8-K/A | Current report | https://www.sec.gov/Archives/edgar/data/1446847/000110465919018301/0001104659-19-018301-index.htm |
| 2019-04-02 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1446847/000110465919019184/0001104659-19-019184-index.htm |
| 2019-04-02 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1446847/000110465919019466/0001104659-19-019466-index.htm |
| 2019-04-04 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1446847/000110465919019969/0001104659-19-019969-index.htm |
| 2019-04-08 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1446847/000110465919020319/0001104659-19-020319-index.htm |
| 2019-05-02 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1446847/000110465919026217/0001104659-19-026217-index.htm |
| 2019-05-03 | 8-K/A | Current report | https://www.sec.gov/Archives/edgar/data/1446847/000110465919026821/0001104659-19-026821-index.htm |
| 2019-05-14 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1446847/000110465919029122/0001104659-19-029122-index.htm |
| 2019-05-31 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1446847/000110465919033121/0001104659-19-033121-index.htm |
| 2019-05-31 | S-8 | Securities to be offered to employees in employee benefit plans | https://www.sec.gov/Archives/edgar/data/1446847/000110465919033182/0001104659-19-033182-index.htm |
| 2019-05-31 | S-8 | Securities to be offered to employees in employee benefit plans | https://www.sec.gov/Archives/edgar/data/1446847/000110465919033185/0001104659-19-033185-index.htm |
| 2019-06-13 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1446847/000110465919035369/0001104659-19-035369-index.htm |
| 2019-07-10 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1446847/000110465919039823/0001104659-19-039823-index.htm |
| 2019-07-22 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1446847/000110465919041287/0001104659-19-041287-index.htm |
| 2019-07-30 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1446847/000110465919042631/0001104659-19-042631-index.htm |
| 2019-10-31 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1446847/000110465919058066/0001104659-19-058066-index.htm |
| 2020-01-13 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1446847/000110465920003250/0001104659-20-003250-index.htm |
| 2020-02-12 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1446847/000110465920017218/0001104659-20-017218-index.htm |
| 2020-02-13 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1446847/000110465920019682/0001104659-20-019682-index.htm |
| 2020-03-16 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1446847/000110465920033605/0001104659-20-033605-index.htm |
| 2020-04-21 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material | https://www.sec.gov/Archives/edgar/data/1446847/000110465920049217/0001104659-20-049217-index.htm |
| 2020-04-21 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1446847/000110465920049220/0001104659-20-049220-index.htm |
| 2020-05-06 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1446847/000110465920057422/0001104659-20-057422-index.htm |
| 2020-06-08 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1446847/000110465920070834/0001104659-20-070834-index.htm |
| 2020-08-06 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1446847/000110465920091113/0001104659-20-091113-index.htm |
| 2020-09-29 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1446847/000110465920109500/0001104659-20-109500-index.htm |
| 2020-11-05 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1446847/000110465920121800/0001104659-20-121800-index.htm |
| 2020-11-06 | S-3ASR | Automatic shelf registration statement of securities of well-known seasoned issuers | https://www.sec.gov/Archives/edgar/data/1446847/000110465920122016/0001104659-20-122016-index.htm |
| 2019-06-10 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1446847/000114420419030427/0001144204-19-030427-index.htm |
| 2019-03-06 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1446847/000120919119017301/0001209191-19-017301-index.htm |
| 2019-03-06 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1446847/000120919119017305/0001209191-19-017305-index.htm |
| 2019-03-06 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1446847/000120919119017525/0001209191-19-017525-index.htm |
| 2019-03-08 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1446847/000120919119018232/0001209191-19-018232-index.htm |
| 2019-03-19 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1446847/000120919119020265/0001209191-19-020265-index.htm |
| 2019-03-19 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1446847/000120919119020268/0001209191-19-020268-index.htm |
| 2019-04-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1446847/000120919119023411/0001209191-19-023411-index.htm |
| 2019-04-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1446847/000120919119023416/0001209191-19-023416-index.htm |
| 2019-04-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1446847/000120919119023419/0001209191-19-023419-index.htm |
| 2019-04-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1446847/000120919119023423/0001209191-19-023423-index.htm |
| 2019-04-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1446847/000120919119023427/0001209191-19-023427-index.htm |
| 2019-04-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1446847/000120919119023429/0001209191-19-023429-index.htm |
| 2019-04-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1446847/000120919119023430/0001209191-19-023430-index.htm |
| 2019-04-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1446847/000120919119023431/0001209191-19-023431-index.htm |
| 2019-04-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1446847/000120919119023433/0001209191-19-023433-index.htm |
| 2019-04-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1446847/000120919119023438/0001209191-19-023438-index.htm |
| 2019-04-03 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1446847/000120919119023456/0001209191-19-023456-index.htm |
| 2019-04-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1446847/000120919119023457/0001209191-19-023457-index.htm |
| 2019-04-03 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1446847/000120919119023458/0001209191-19-023458-index.htm |
| 2019-04-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1446847/000120919119023459/0001209191-19-023459-index.htm |
| 2019-04-03 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1446847/000120919119023462/0001209191-19-023462-index.htm |
| 2019-04-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1446847/000120919119023463/0001209191-19-023463-index.htm |
| 2019-04-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1446847/000120919119023482/0001209191-19-023482-index.htm |
| 2019-05-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1446847/000120919119027346/0001209191-19-027346-index.htm |
| 2019-05-14 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1446847/000120919119029596/0001209191-19-029596-index.htm |
| 2019-05-14 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1446847/000120919119029601/0001209191-19-029601-index.htm |
| 2019-05-14 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1446847/000120919119029605/0001209191-19-029605-index.htm |
| 2019-05-14 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1446847/000120919119029609/0001209191-19-029609-index.htm |
| 2019-05-31 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1446847/000120919119033615/0001209191-19-033615-index.htm |
| 2019-05-31 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1446847/000120919119033621/0001209191-19-033621-index.htm |
| 2019-05-31 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1446847/000120919119033624/0001209191-19-033624-index.htm |
| 2019-05-31 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1446847/000120919119033627/0001209191-19-033627-index.htm |
| 2019-05-31 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1446847/000120919119033630/0001209191-19-033630-index.htm |
| 2019-05-31 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1446847/000120919119033633/0001209191-19-033633-index.htm |
| 2019-05-31 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1446847/000120919119033637/0001209191-19-033637-index.htm |
| 2019-05-31 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1446847/000120919119033645/0001209191-19-033645-index.htm |
| 2019-06-07 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1446847/000120919119035509/0001209191-19-035509-index.htm |
| 2019-06-07 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1446847/000120919119035513/0001209191-19-035513-index.htm |
| 2019-06-18 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1446847/000120919119037676/0001209191-19-037676-index.htm |
| 2019-07-11 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1446847/000120919119041824/0001209191-19-041824-index.htm |
| 2019-07-11 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1446847/000120919119041827/0001209191-19-041827-index.htm |
| 2019-07-30 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1446847/000120919119043685/0001209191-19-043685-index.htm |
| 2019-08-20 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1446847/000120919119046846/0001209191-19-046846-index.htm |
| 2019-09-04 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1446847/000120919119048225/0001209191-19-048225-index.htm |
| 2019-09-16 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1446847/000120919119049666/0001209191-19-049666-index.htm |
| 2019-11-12 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1446847/000120919119056188/0001209191-19-056188-index.htm |
| 2019-11-12 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1446847/000120919119056191/0001209191-19-056191-index.htm |
| 2019-12-17 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1446847/000120919119060843/0001209191-19-060843-index.htm |
| 2019-12-18 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1446847/000120919119061129/0001209191-19-061129-index.htm |
| 2019-12-18 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1446847/000120919119061132/0001209191-19-061132-index.htm |
| 2019-12-18 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1446847/000120919119061134/0001209191-19-061134-index.htm |
| 2019-12-18 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1446847/000120919119061135/0001209191-19-061135-index.htm |
| 2019-12-18 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1446847/000120919119061136/0001209191-19-061136-index.htm |
| 2020-01-21 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1446847/000120919120004301/0001209191-20-004301-index.htm |
| 2020-01-24 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1446847/000120919120004855/0001209191-20-004855-index.htm |
| 2020-01-28 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1446847/000120919120005129/0001209191-20-005129-index.htm |
| 2020-02-04 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1446847/000120919120006267/0001209191-20-006267-index.htm |
| 2020-02-25 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1446847/000120919120012474/0001209191-20-012474-index.htm |
| 2020-02-25 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1446847/000120919120012479/0001209191-20-012479-index.htm |
| 2020-02-25 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1446847/000120919120012484/0001209191-20-012484-index.htm |
| 2020-02-25 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1446847/000120919120012490/0001209191-20-012490-index.htm |
| 2020-02-25 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1446847/000120919120012528/0001209191-20-012528-index.htm |
| 2020-03-02 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1446847/000120919120014402/0001209191-20-014402-index.htm |
| 2020-03-02 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1446847/000120919120014464/0001209191-20-014464-index.htm |
| 2020-03-02 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1446847/000120919120014467/0001209191-20-014467-index.htm |
| 2020-03-02 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1446847/000120919120014476/0001209191-20-014476-index.htm |
| 2020-03-17 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1446847/000120919120019543/0001209191-20-019543-index.htm |
| 2020-04-21 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1446847/000120919120025240/0001209191-20-025240-index.htm |
| 2020-04-21 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1446847/000120919120025241/0001209191-20-025241-index.htm |
| 2020-04-21 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1446847/000120919120025257/0001209191-20-025257-index.htm |
| 2020-04-28 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1446847/000120919120025917/0001209191-20-025917-index.htm |
| 2020-04-28 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1446847/000120919120025918/0001209191-20-025918-index.htm |
| 2020-05-13 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1446847/000120919120028895/0001209191-20-028895-index.htm |
| 2020-05-13 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1446847/000120919120028899/0001209191-20-028899-index.htm |
| 2020-05-13 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1446847/000120919120028900/0001209191-20-028900-index.htm |
| 2020-05-13 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1446847/000120919120028903/0001209191-20-028903-index.htm |
| 2020-05-13 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1446847/000120919120028906/0001209191-20-028906-index.htm |
| 2020-06-05 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1446847/000120919120034692/0001209191-20-034692-index.htm |
| 2020-06-05 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1446847/000120919120034693/0001209191-20-034693-index.htm |
| 2020-06-05 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1446847/000120919120034694/0001209191-20-034694-index.htm |
| 2020-06-05 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1446847/000120919120034695/0001209191-20-034695-index.htm |
| 2020-06-05 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1446847/000120919120034696/0001209191-20-034696-index.htm |
| 2020-06-05 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1446847/000120919120034697/0001209191-20-034697-index.htm |
| 2020-06-05 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1446847/000120919120034699/0001209191-20-034699-index.htm |
| 2020-06-05 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1446847/000120919120034700/0001209191-20-034700-index.htm |
| 2020-06-12 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1446847/000120919120036289/0001209191-20-036289-index.htm |
| 2020-06-16 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1446847/000120919120037035/0001209191-20-037035-index.htm |
| 2020-08-19 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1446847/000120919120047469/0001209191-20-047469-index.htm |
| 2020-08-19 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1446847/000120919120047472/0001209191-20-047472-index.htm |
| 2020-09-09 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1446847/000120919120049868/0001209191-20-049868-index.htm |
| 2020-09-17 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1446847/000120919120050875/0001209191-20-050875-index.htm |
| 2020-10-13 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1446847/000120919120054621/0001209191-20-054621-index.htm |
| 2020-02-14 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1446847/000127417320000094/0001274173-20-000094-index.htm |
| 2019-09-09 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1446847/000139834419016261/0001398344-19-016261-index.htm |
| 2020-02-14 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1446847/000139834420003413/0001398344-20-003413-index.htm |
| 2019-08-01 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1446847/000141057819000630/0001410578-19-000630-index.htm |
| 2019-08-13 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1446847/000141057819000770/0001410578-19-000770-index.htm |
| 2019-08-14 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1446847/000141057819000778/0001410578-19-000778-index.htm |
| 2019-09-16 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1446847/000141057819001260/0001410578-19-001260-index.htm |
| 2019-09-18 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1446847/000141057819001289/0001410578-19-001289-index.htm |
| 2019-05-02 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1446847/000155837019003848/0001558370-19-003848-index.htm |
| 2019-07-30 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1446847/000155837019006578/0001558370-19-006578-index.htm |
| 2019-10-31 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1446847/000155837019009567/0001558370-19-009567-index.htm |
| 2020-02-13 | 10-K | Annual report [Section 13 and 15(d), not S-K Item 405] | https://www.sec.gov/Archives/edgar/data/1446847/000155837020000779/0001558370-20-000779-index.htm |
| 2020-05-06 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1446847/000155837020005460/0001558370-20-005460-index.htm |
| 2020-08-06 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1446847/000155837020009637/0001558370-20-009637-index.htm |
| 2020-11-05 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1446847/000155837020012918/0001558370-20-012918-index.htm |
| 2019-03-19 | CT ORDER | Confidential treatment order | https://www.sec.gov/Archives/edgar/data/1446847/999999999719001495/9999999997-19-001495-index.htm |
| 2019-04-26 | CT ORDER | Confidential treatment order | https://www.sec.gov/Archives/edgar/data/1446847/999999999719003532/9999999997-19-003532-index.htm |
| 2019-04-26 | CT ORDER | Confidential treatment order | https://www.sec.gov/Archives/edgar/data/1446847/999999999719003534/9999999997-19-003534-index.htm |
Ironwood Pharmaceuticals, Inc (IRWD) Insider Transactions:
Here you will find a list of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Ironwood Pharmaceuticals, Inc (IRWD). Company insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.Insider Ownership: 296%Institutional Ownership: 10852%
| Transaction Date | Insider Name | Insider Title | Type | Shares Number | Shares Price | Total Transaction | Shares Held After Transaction | Link |
|---|---|---|---|---|---|---|---|---|
| 2019-04-01 | Mark Mallon | Chief Executive Officer | Buy | 11,500.00 | 104,536.00 | https://www.sec.gov/Archives/edgar/data/1446847/000120919119023482/0001209191-19-023482-index.htm | ||
| 2020-04-24 | Michael Shetzline | CMO, SVP & Head of Drug Devt. | Buy | 20,740.00 | 107,046.00 | https://www.sec.gov/Archives/edgar/data/1446847/000120919120025918/0001209191-20-025918-index.htm | ||
| 2019-05-10 | Thomas A MCCOURT | President | Sell | 4,055.00 | 10.53 | 42,699.15 | 107,239.00 | https://www.sec.gov/Archives/edgar/data/1446847/000120919119029609/0001209191-19-029609-index.htm |
| 2020-06-03 | Andrew Dreyfus | Director | Buy | 21,720.00 | 108,658.00 | https://www.sec.gov/Archives/edgar/data/1446847/000120919120034693/0001209191-20-034693-index.htm | ||
| 2019-06-05 | Julie McHugh | Director | Sell | 1,500.00 | 11.26 | 16,890.00 | 109,337.00 | https://www.sec.gov/Archives/edgar/data/1446847/000120919119035509/0001209191-19-035509-index.htm |
| 2019-08-30 | Thomas A MCCOURT | President | Sell | 220,000.00 | 9.24 | 2,032,800.00 | 109,739.00 | https://www.sec.gov/Archives/edgar/data/1446847/000120919119048225/0001209191-19-048225-index.htm |
| 2020-06-15 | Andrew Dreyfus | Director | Buy | 1,745.00 | 110,403.00 | https://www.sec.gov/Archives/edgar/data/1446847/000120919120037035/0001209191-20-037035-index.htm | ||
| 2019-05-29 | Julie McHugh | Director | Buy | 22,706.00 | 110,837.00 | https://www.sec.gov/Archives/edgar/data/1446847/000120919119033630/0001209191-19-033630-index.htm | ||
| 2019-05-01 | Thomas A MCCOURT | President | Buy | 22,852.00 | 111,294.00 | https://www.sec.gov/Archives/edgar/data/1446847/000120919119027346/0001209191-19-027346-index.htm | ||
| 2020-09-15 | Andrew Dreyfus | Director | Buy | 1,600.00 | 112,003.00 | https://www.sec.gov/Archives/edgar/data/1446847/000120919120050875/0001209191-20-050875-index.htm | ||
| 2020-05-11 | Kelly MacDonald | Chief Accounting Officer | Sell | 595.00 | 10.35 | 6,158.25 | 118,147.00 | https://www.sec.gov/Archives/edgar/data/1446847/000120919120028899/0001209191-20-028899-index.htm |
| 2020-08-17 | Kelly MacDonald | Chief Accounting Officer | Sell | 575.00 | 10.14 | 5,830.50 | 118,552.00 | https://www.sec.gov/Archives/edgar/data/1446847/000120919120047469/0001209191-20-047469-index.htm |
| 2020-05-11 | Kelly MacDonald | Chief Accounting Officer | Sell | 558.00 | 10.35 | 5,775.30 | 118,742.00 | https://www.sec.gov/Archives/edgar/data/1446847/000120919120028899/0001209191-20-028899-index.htm |
| 2020-02-27 | Kelly MacDonald | Chief Accounting Officer | Buy | 36,173.00 | 119,300.00 | https://www.sec.gov/Archives/edgar/data/1446847/000120919120014464/0001209191-20-014464-index.htm | ||
| 2020-09-08 | Julie McHugh | Director | Sell | 7,950.00 | 9.77 | 77,671.50 | 123,107.00 | https://www.sec.gov/Archives/edgar/data/1446847/000120919120049868/0001209191-20-049868-index.htm |
| 2020-05-11 | Conor Kilroy | SVP, GC & Secretary | Sell | 558.00 | 10.35 | 5,775.30 | 128,921.00 | https://www.sec.gov/Archives/edgar/data/1446847/000120919120028895/0001209191-20-028895-index.htm |
| 2020-05-11 | Conor Kilroy | SVP, GC & Secretary | Sell | 158.00 | 10.35 | 1,635.30 | 129,479.00 | https://www.sec.gov/Archives/edgar/data/1446847/000120919120028895/0001209191-20-028895-index.htm |
| 2020-04-24 | Conor Kilroy | SVP, GC & Secretary | Buy | 22,814.00 | 129,637.00 | https://www.sec.gov/Archives/edgar/data/1446847/000120919120025917/0001209191-20-025917-index.htm | ||
| 2020-06-03 | Julie McHugh | Director | Buy | 21,720.00 | 131,057.00 | https://www.sec.gov/Archives/edgar/data/1446847/000120919120034696/0001209191-20-034696-index.htm | ||
| 2019-04-01 | Marsha Fanucci | Director | Sell | 4,056.00 | 132,663.00 | https://www.sec.gov/Archives/edgar/data/1446847/000120919119023411/0001209191-19-023411-index.htm | ||
| 2019-03-29 | IRONWOOD PHARMACEUTICALS INC | 10% Share Holder | Buy | 15,562,455.00 | 15,562,555.00 | https://www.sec.gov/Archives/edgar/data/1446847/000110465919019466/0001104659-19-019466-index.htm | ||
| 2019-11-08 | Gina Consylman | SVP, CFO & Treasurer | Sell | 630.00 | 11.00 | 6,930.00 | 174,138.00 | https://www.sec.gov/Archives/edgar/data/1446847/000120919119056188/0001209191-19-056188-index.htm |
| 2019-11-08 | Gina Consylman | SVP, CFO & Treasurer | Sell | 880.00 | 11.00 | 9,680.00 | 174,768.00 | https://www.sec.gov/Archives/edgar/data/1446847/000120919119056188/0001209191-19-056188-index.htm |
| 2019-08-16 | Gina Consylman | SVP, CFO & Treasurer | Sell | 212.00 | 9.04 | 1,916.48 | 175,648.00 | https://www.sec.gov/Archives/edgar/data/1446847/000120919119046846/0001209191-19-046846-index.htm |
| 2019-05-10 | Gina Consylman | SVP, CFO & Treasurer | Sell | 4,055.00 | 10.53 | 42,699.15 | 175,860.00 | https://www.sec.gov/Archives/edgar/data/1446847/000120919119029596/0001209191-19-029596-index.htm |
| 2019-04-01 | Gina Consylman | SVP, CFO & Treasurer | Buy | 16,731.00 | 179,915.00 | https://www.sec.gov/Archives/edgar/data/1446847/000120919119023430/0001209191-19-023430-index.htm | ||
| 2019-05-29 | Edward P Owens | Director | Buy | 22,706.00 | 182,234.00 | https://www.sec.gov/Archives/edgar/data/1446847/000120919119033645/0001209191-19-033645-index.htm | ||
| 2019-08-30 | Thomas A MCCOURT | President | Buy | 90,000.00 | 4.88 | 439,200.00 | 199,739.00 | https://www.sec.gov/Archives/edgar/data/1446847/000120919119048225/0001209191-19-048225-index.htm |
| 2020-02-21 | Gina Consylman | SVP, CFO & Treasurer | Sell | 6,181.00 | 11.63 | 71,885.03 | 202,787.00 | https://www.sec.gov/Archives/edgar/data/1446847/000120919120012474/0001209191-20-012474-index.htm |
| 2020-06-03 | Edward P Owens | Director | Buy | 21,720.00 | 203,954.00 | https://www.sec.gov/Archives/edgar/data/1446847/000120919120034700/0001209191-20-034700-index.htm | ||
| 2020-02-21 | Gina Consylman | SVP, CFO & Treasurer | Sell | 2,558.00 | 11.63 | 29,749.54 | 208,968.00 | https://www.sec.gov/Archives/edgar/data/1446847/000120919120012474/0001209191-20-012474-index.htm |
| 2020-02-21 | Gina Consylman | SVP, CFO & Treasurer | Sell | 2,252.00 | 11.63 | 26,190.76 | 211,526.00 | https://www.sec.gov/Archives/edgar/data/1446847/000120919120012474/0001209191-20-012474-index.htm |
| 2020-02-21 | Gina Consylman | SVP, CFO & Treasurer | Sell | 1,510.00 | 11.63 | 17,561.30 | 213,778.00 | https://www.sec.gov/Archives/edgar/data/1446847/000120919120012474/0001209191-20-012474-index.htm |
| 2019-12-16 | Gina Consylman | SVP, CFO & Treasurer | Buy | 41,150.00 | 215,288.00 | https://www.sec.gov/Archives/edgar/data/1446847/000120919119061129/0001209191-19-061129-index.htm | ||
| 2020-02-21 | Thomas A MCCOURT | President | Sell | 1,865.00 | 11.63 | 21,689.95 | 221,062.00 | https://www.sec.gov/Archives/edgar/data/1446847/000120919120012490/0001209191-20-012490-index.htm |
| 2020-02-21 | Thomas A MCCOURT | President | Sell | 2,312.00 | 11.63 | 26,888.56 | 222,927.00 | https://www.sec.gov/Archives/edgar/data/1446847/000120919120012490/0001209191-20-012490-index.htm |
| 2019-12-16 | Thomas A MCCOURT | President | Buy | 115,220.00 | 224,959.00 | https://www.sec.gov/Archives/edgar/data/1446847/000120919119061135/0001209191-19-061135-index.htm | ||
| 2020-01-24 | Thomas A MCCOURT | President | Sell | 20,000.00 | 12.71 | 254,200.00 | 225,239.00 | https://www.sec.gov/Archives/edgar/data/1446847/000120919120005129/0001209191-20-005129-index.htm |
| 2020-05-11 | Jason Rickard | SVP, Chief Operating Officer | Sell | 510.00 | 10.35 | 5,278.50 | 234,580.00 | https://www.sec.gov/Archives/edgar/data/1446847/000120919120028906/0001209191-20-028906-index.htm |
| 2020-08-17 | Jason Rickard | SVP, Chief Operating Officer | Sell | 689.00 | 10.14 | 6,986.46 | 235,776.00 | https://www.sec.gov/Archives/edgar/data/1446847/000120919120047472/0001209191-20-047472-index.htm |
| 2019-05-10 | Halley E Gilbert | Chief Admin Officer & SVP | Sell | 4,055.00 | 10.53 | 42,699.15 | 238,240.00 | https://www.sec.gov/Archives/edgar/data/1446847/000120919119029605/0001209191-19-029605-index.htm |
| 2019-07-26 | Halley E Gilbert | Chief Admin Officer & SVP | Sell | 20,000.00 | 10.00 | 200,000.00 | 240,169.00 | https://www.sec.gov/Archives/edgar/data/1446847/000120919119043685/0001209191-19-043685-index.htm |
| 2019-04-01 | Halley E Gilbert | Chief Admin Officer & SVP | Buy | 17,165.00 | 242,295.00 | https://www.sec.gov/Archives/edgar/data/1446847/000120919119023431/0001209191-19-023431-index.htm | ||
| 2020-01-24 | Thomas A MCCOURT | President | Buy | 20,000.00 | 10.02 | 200,400.00 | 245,239.00 | https://www.sec.gov/Archives/edgar/data/1446847/000120919120005129/0001209191-20-005129-index.htm |
| 2019-05-29 | Catherine Moukheibir | Director | Buy | 22,706.00 | 25,701.00 | https://www.sec.gov/Archives/edgar/data/1446847/000120919119033633/0001209191-19-033633-index.htm | ||
| 2019-05-29 | Jon R Duane | Director | Buy | 22,706.00 | 25,701.00 | https://www.sec.gov/Archives/edgar/data/1446847/000120919119033624/0001209191-19-033624-index.htm | ||
| 2019-05-29 | Marla L Kessler | Director | Buy | 22,706.00 | 25,701.00 | https://www.sec.gov/Archives/edgar/data/1446847/000120919119033627/0001209191-19-033627-index.htm | ||
| 2019-07-26 | Halley E Gilbert | Chief Admin Officer & SVP | Buy | 20,000.00 | 4.88 | 97,600.00 | 260,169.00 | https://www.sec.gov/Archives/edgar/data/1446847/000120919119043685/0001209191-19-043685-index.htm |
| 2019-04-01 | William Huyett | Chief Operating Officer | Sell | 85,312.00 | 26,063.00 | https://www.sec.gov/Archives/edgar/data/1446847/000120919119023429/0001209191-19-023429-index.htm | ||
| 2020-02-21 | Halley E Gilbert | Chief Admin Officer & SVP | Sell | 6,181.00 | 11.63 | 71,885.03 | 265,991.00 | https://www.sec.gov/Archives/edgar/data/1446847/000120919120012479/0001209191-20-012479-index.htm |
| 2020-02-27 | Gina Consylman | SVP, CFO & Treasurer | Buy | 68,327.00 | 271,114.00 | https://www.sec.gov/Archives/edgar/data/1446847/000120919120014402/0001209191-20-014402-index.htm | ||
| 2020-02-21 | Halley E Gilbert | Chief Admin Officer & SVP | Sell | 2,984.00 | 11.63 | 34,703.92 | 272,172.00 | https://www.sec.gov/Archives/edgar/data/1446847/000120919120012479/0001209191-20-012479-index.htm |
| 2020-02-21 | Halley E Gilbert | Chief Admin Officer & SVP | Sell | 3,410.00 | 11.63 | 39,658.30 | 275,156.00 | https://www.sec.gov/Archives/edgar/data/1446847/000120919120012479/0001209191-20-012479-index.htm |
| 2019-04-01 | William Huyett | Chief Operating Officer | Buy | 1,483.00 | 27,546.00 | https://www.sec.gov/Archives/edgar/data/1446847/000120919119023429/0001209191-19-023429-index.htm | ||
| 2020-02-21 | Halley E Gilbert | Chief Admin Officer & SVP | Sell | 2,753.00 | 11.63 | 32,017.39 | 278,566.00 | https://www.sec.gov/Archives/edgar/data/1446847/000120919120012479/0001209191-20-012479-index.htm |
| 2019-12-16 | Halley E Gilbert | Chief Admin Officer & SVP | Buy | 41,150.00 | 281,319.00 | https://www.sec.gov/Archives/edgar/data/1446847/000120919119061132/0001209191-19-061132-index.htm | ||
| 2020-01-31 | Halley E Gilbert | Chief Admin Officer & SVP | Sell | 60,000.00 | 12.05 | 723,000.00 | 281,319.00 | https://www.sec.gov/Archives/edgar/data/1446847/000120919120006267/0001209191-20-006267-index.htm |
| 2019-04-01 | Catherine Moukheibir | Director | Buy | 2,995.00 | 2,995.00 | https://www.sec.gov/Archives/edgar/data/1446847/000120919119023463/0001209191-19-023463-index.htm | ||
| 2019-04-01 | Jon R Duane | Director | Buy | 2,995.00 | 2,995.00 | https://www.sec.gov/Archives/edgar/data/1446847/000120919119023457/0001209191-19-023457-index.htm | ||
| 2019-04-01 | Marla L Kessler | Director | Buy | 2,995.00 | 2,995.00 | https://www.sec.gov/Archives/edgar/data/1446847/000120919119023459/0001209191-19-023459-index.htm | ||
| 2020-02-24 | Mark Mallon | Chief Executive Officer | Sell | 1.00 | 11.25 | 11.25 | 303,425.00 | https://www.sec.gov/Archives/edgar/data/1446847/000120919120012528/0001209191-20-012528-index.htm |
| 2020-02-21 | Mark Mallon | Chief Executive Officer | Sell | 7,983.00 | 11.63 | 92,842.29 | 303,426.00 | https://www.sec.gov/Archives/edgar/data/1446847/000120919120012528/0001209191-20-012528-index.htm |
| 2019-04-01 | Mark Mallon | Chief Executive Officer | Buy | 206,873.00 | 311,409.00 | https://www.sec.gov/Archives/edgar/data/1446847/000120919119023482/0001209191-19-023482-index.htm | ||
| 2020-05-11 | Thomas A MCCOURT | President | Sell | 1,697.00 | 10.35 | 17,563.95 | 319,847.00 | https://www.sec.gov/Archives/edgar/data/1446847/000120919120028903/0001209191-20-028903-index.htm |
| 2020-02-27 | Thomas A MCCOURT | President | Buy | 100,482.00 | 321,544.00 | https://www.sec.gov/Archives/edgar/data/1446847/000120919120014476/0001209191-20-014476-index.htm | ||
| 2019-08-30 | Thomas A MCCOURT | President | Buy | 130,000.00 | 4.88 | 634,400.00 | 329,739.00 | https://www.sec.gov/Archives/edgar/data/1446847/000120919119048225/0001209191-19-048225-index.htm |
| 2020-01-31 | Halley E Gilbert | Chief Admin Officer & SVP | Buy | 60,000.00 | 10.02 | 601,200.00 | 341,319.00 | https://www.sec.gov/Archives/edgar/data/1446847/000120919120006267/0001209191-20-006267-index.htm |
| 2019-03-05 | LAWRENCE S OLANOFF | Director | Sell | 2,000.00 | 14.41 | 28,820.00 | 37,553.00 | https://www.sec.gov/Archives/edgar/data/1446847/000120919119017301/0001209191-19-017301-index.htm |
| 2019-04-01 | AMY W SCHULMAN | Director | Sell | 4,056.00 | 38,242.00 | https://www.sec.gov/Archives/edgar/data/1446847/000120919119023419/0001209191-19-023419-index.htm | ||
| 2019-03-15 | AMY W SCHULMAN | Director | Buy | 183.00 | 42,298.00 | https://www.sec.gov/Archives/edgar/data/1446847/000120919119020265/0001209191-19-020265-index.htm | ||
| 2020-06-03 | Catherine Moukheibir | Director | Buy | 21,720.00 | 47,421.00 | https://www.sec.gov/Archives/edgar/data/1446847/000120919120034697/0001209191-20-034697-index.htm | ||
| 2020-06-03 | Jon R Duane | Director | Buy | 21,720.00 | 47,421.00 | https://www.sec.gov/Archives/edgar/data/1446847/000120919120034694/0001209191-20-034694-index.htm | ||
| 2020-06-03 | Marla L Kessler | Director | Buy | 21,720.00 | 47,421.00 | https://www.sec.gov/Archives/edgar/data/1446847/000120919120034695/0001209191-20-034695-index.htm | ||
| 2020-05-11 | Mark Mallon | Chief Executive Officer | Sell | 23,206.00 | 10.35 | 240,182.10 | 501,280.00 | https://www.sec.gov/Archives/edgar/data/1446847/000120919120028900/0001209191-20-028900-index.htm |
| 2020-02-27 | Mark Mallon | Chief Executive Officer | Buy | 221,061.00 | 524,486.00 | https://www.sec.gov/Archives/edgar/data/1446847/000120919120014467/0001209191-20-014467-index.htm | ||
| 2019-03-08 | Mark G Currie | Chief Scientific Officer | Sell | 49,500.00 | 13.15 | 650,925.00 | 528,480.00 | https://www.sec.gov/Archives/edgar/data/1446847/000120919119018232/0001209191-19-018232-index.htm |
| 2019-05-10 | Mark G Currie | Director | Sell | 4,055.00 | 10.53 | 42,699.15 | 528,903.00 | https://www.sec.gov/Archives/edgar/data/1446847/000120919119029601/0001209191-19-029601-index.htm |
| 2019-04-01 | Mark G Currie | Director | Buy | 1,483.00 | 529,963.00 | https://www.sec.gov/Archives/edgar/data/1446847/000120919119023438/0001209191-19-023438-index.htm | ||
| 2019-04-01 | Mark G Currie | Director | Buy | 2,995.00 | 532,958.00 | https://www.sec.gov/Archives/edgar/data/1446847/000120919119023438/0001209191-19-023438-index.htm | ||
| 2020-01-16 | Mark G Currie | Director | Sell | 8,888.00 | 12.80 | 113,766.40 | 549,272.00 | https://www.sec.gov/Archives/edgar/data/1446847/000120919120004301/0001209191-20-004301-index.htm |
| 2020-01-23 | Mark G Currie | Director | Sell | 60,000.00 | 12.59 | 755,400.00 | 549,272.00 | https://www.sec.gov/Archives/edgar/data/1446847/000120919120004855/0001209191-20-004855-index.htm |
| 2019-05-29 | Mark G Currie | Director | Buy | 22,706.00 | 551,609.00 | https://www.sec.gov/Archives/edgar/data/1446847/000120919119033615/0001209191-19-033615-index.htm | ||
| 2020-01-16 | Mark G Currie | Director | Buy | 8,888.00 | 10.02 | 89,057.76 | 558,160.00 | https://www.sec.gov/Archives/edgar/data/1446847/000120919120004301/0001209191-20-004301-index.htm |
| 2020-06-03 | Mark G Currie | Director | Buy | 21,720.00 | 570,992.00 | https://www.sec.gov/Archives/edgar/data/1446847/000120919120034692/0001209191-20-034692-index.htm | ||
| 2019-03-07 | Mark G Currie | Chief Scientific Officer | Sell | 225,500.00 | 13.29 | 2,996,895.00 | 577,980.00 | https://www.sec.gov/Archives/edgar/data/1446847/000120919119018232/0001209191-19-018232-index.htm |
| 2019-06-05 | LAWRENCE S OLANOFF | Director | Sell | 2,000.00 | 11.25 | 22,500.00 | 58,259.00 | https://www.sec.gov/Archives/edgar/data/1446847/000120919119035513/0001209191-19-035513-index.htm |
| 2019-05-29 | LAWRENCE S OLANOFF | Director | Buy | 22,706.00 | 60,259.00 | https://www.sec.gov/Archives/edgar/data/1446847/000120919119033637/0001209191-19-033637-index.htm | ||
| 2020-01-23 | Mark G Currie | Director | Buy | 60,000.00 | 9.12 | 547,200.00 | 609,272.00 | https://www.sec.gov/Archives/edgar/data/1446847/000120919120004855/0001209191-20-004855-index.htm |
| 2020-06-10 | LAWRENCE S OLANOFF | Director | Sell | 11,350.00 | 10.06 | 114,181.00 | 68,629.00 | https://www.sec.gov/Archives/edgar/data/1446847/000120919120036289/0001209191-20-036289-index.htm |
| 2019-04-01 | TERRANCE MCGUIRE | Director | Sell | 4,056.00 | 73,630.00 | https://www.sec.gov/Archives/edgar/data/1446847/000120919119023416/0001209191-19-023416-index.htm | ||
| 2019-03-15 | TERRANCE MCGUIRE | Director | Buy | 183.00 | 77,686.00 | https://www.sec.gov/Archives/edgar/data/1446847/000120919119020268/0001209191-19-020268-index.htm | ||
| 2019-11-08 | Kelly MacDonald | Chief Accounting Officer | Sell | 107.00 | 11.00 | 1,177.00 | 78,337.00 | https://www.sec.gov/Archives/edgar/data/1446847/000120919119056191/0001209191-19-056191-index.htm |
| 2019-11-08 | Kelly MacDonald | Chief Accounting Officer | Sell | 880.00 | 11.00 | 9,680.00 | 78,444.00 | https://www.sec.gov/Archives/edgar/data/1446847/000120919119056191/0001209191-19-056191-index.htm |
| 2019-07-09 | Kelly MacDonald | Chief Accounting Officer | Buy | 7,500.00 | 79,324.00 | https://www.sec.gov/Archives/edgar/data/1446847/000120919119041827/0001209191-19-041827-index.htm | ||
| 2020-06-03 | LAWRENCE S OLANOFF | Director | Buy | 21,720.00 | 79,979.00 | https://www.sec.gov/Archives/edgar/data/1446847/000120919120034699/0001209191-20-034699-index.htm | ||
| 2019-05-29 | Andrew Dreyfus | Director | Buy | 22,706.00 | 80,813.00 | https://www.sec.gov/Archives/edgar/data/1446847/000120919119033621/0001209191-19-033621-index.htm | ||
| 2019-06-14 | Andrew Dreyfus | Director | Buy | 1,567.00 | 82,380.00 | https://www.sec.gov/Archives/edgar/data/1446847/000120919119037676/0001209191-19-037676-index.htm | ||
| 2020-02-21 | Kelly MacDonald | Chief Accounting Officer | Sell | 1,695.00 | 11.63 | 19,712.85 | 83,127.00 | https://www.sec.gov/Archives/edgar/data/1446847/000120919120012484/0001209191-20-012484-index.htm |
| 2019-09-13 | Andrew Dreyfus | Director | Buy | 1,692.00 | 84,072.00 | https://www.sec.gov/Archives/edgar/data/1446847/000120919119049666/0001209191-19-049666-index.htm | ||
| 2020-02-21 | Kelly MacDonald | Chief Accounting Officer | Sell | 303.00 | 11.63 | 3,523.89 | 84,822.00 | https://www.sec.gov/Archives/edgar/data/1446847/000120919120012484/0001209191-20-012484-index.htm |
| 2020-02-21 | Kelly MacDonald | Chief Accounting Officer | Sell | 793.00 | 11.63 | 9,222.59 | 85,125.00 | https://www.sec.gov/Archives/edgar/data/1446847/000120919120012484/0001209191-20-012484-index.htm |
| 2019-12-13 | Andrew Dreyfus | Director | Buy | 1,270.00 | 85,342.00 | https://www.sec.gov/Archives/edgar/data/1446847/000120919119060843/0001209191-19-060843-index.htm | ||
| 2020-02-21 | Kelly MacDonald | Chief Accounting Officer | Sell | 303.00 | 11.63 | 3,523.89 | 85,918.00 | https://www.sec.gov/Archives/edgar/data/1446847/000120919120012484/0001209191-20-012484-index.htm |
| 2020-02-21 | Kelly MacDonald | Chief Accounting Officer | Sell | 504.00 | 11.63 | 5,861.52 | 86,221.00 | https://www.sec.gov/Archives/edgar/data/1446847/000120919120012484/0001209191-20-012484-index.htm |
| 2019-12-16 | Kelly MacDonald | Chief Accounting Officer | Buy | 8,230.00 | 86,567.00 | https://www.sec.gov/Archives/edgar/data/1446847/000120919119061134/0001209191-19-061134-index.htm | ||
| 2020-02-21 | Kelly MacDonald | Chief Accounting Officer | Sell | 302.00 | 11.63 | 3,512.26 | 86,725.00 | https://www.sec.gov/Archives/edgar/data/1446847/000120919120012484/0001209191-20-012484-index.htm |
| 2020-03-13 | Andrew Dreyfus | Director | Buy | 1,596.00 | 86,938.00 | https://www.sec.gov/Archives/edgar/data/1446847/000120919120019543/0001209191-20-019543-index.htm | ||
| 2019-04-01 | DOUGLAS E WILLIAMS | Director | Sell | 4,056.00 | 87,800.00 | https://www.sec.gov/Archives/edgar/data/1446847/000120919119023423/0001209191-19-023423-index.htm | ||
| 2019-03-05 | Julie McHugh | Director | Sell | 1,500.00 | 14.38 | 21,570.00 | 88,131.00 | https://www.sec.gov/Archives/edgar/data/1446847/000120919119017305/0001209191-19-017305-index.htm |
| 2019-04-01 | Thomas A MCCOURT | President | Buy | 5,133.00 | 88,442.00 | https://www.sec.gov/Archives/edgar/data/1446847/000120919119023433/0001209191-19-023433-index.htm | ||
| 2020-10-08 | Kelly MacDonald | Chief Accounting Officer | Sell | 22,714.00 | 10.50 | 238,497.00 | 95,838.00 | https://www.sec.gov/Archives/edgar/data/1446847/000120919120054621/0001209191-20-054621-index.htm |